•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A08482 Summary:

BILL NOA08482
 
SAME ASSAME AS S08016
 
SPONSORSeawright
 
COSPNSRSayegh
 
MLTSPNSR
 
Amd §207, Pub Health L (as proposed in S.5399 & A.5627)
 
Requires the department of health to conduct a public information and outreach campaign on medically unnecessary treatments on persons born with intersex traits.
Go to top    

A08482 Actions:

BILL NOA08482
 
01/03/2024referred to health
01/17/2024reported
01/18/2024advanced to third reading cal.234
01/22/2024substituted by s8016
 S08016 AMEND= HOYLMAN-SIGAL
 01/05/2024REFERRED TO RULES
 01/08/2024ORDERED TO THIRD READING CAL.25
 01/17/2024PASSED SENATE
 01/17/2024DELIVERED TO ASSEMBLY
 01/17/2024referred to health
 01/22/2024substituted for a8482
 01/22/2024ordered to third reading cal.234
 01/22/2024passed assembly
 01/22/2024returned to senate
 01/26/2024DELIVERED TO GOVERNOR
 01/26/2024SIGNED CHAP.11
Go to top

A08482 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A8482
 
SPONSOR: Seawright
  TITLE OF BILL: An act to amend the public health law, in relation to treatments on persons born with intersex traits   PURPOSE: To make clarifying amendments to terms and ensure that department consults with appropriate stakeholders when creating the outreach program   SUMMARY OF PROVISIONS: This bill amends Chapter 608 of the Laws of 2023 by changing two terms; removing "nonemergent" to ensure the education and outreach program is inclusive of both emergent and nonemergent treatment as well as changing "individuals with variations in sex characteristics" to "intersex indi- viduals" to reflect the term intersex individuals prefer. The bill also replaces the advisory council with a stakeholder consultation process.   JUSTIFICATION: There are over 30 intersex variations, resulting in congenital vari- ations in sex characteristics that occur in at least 1.7% of the popu- lation. In the majority of cases, infants and children born with vari- ations in sex characteristics do not require medical treatments for their immediate physical health. Nevertheless, many intersex youth are subjected to non-emergent medical procedures, including sterilization, to make them fit into restrictive male-female binary categories. These non-emergent medical procedures are classified as human rights violations by the United Nations. This bill aims to respond to these harms and bring attention to the natural existence of people born with intersex traits and the risks associated with non-emergent medical procedures often recommended for and performed on them. It encourages the Department of Health to conduct public outreach campaigns to inform parents and the medical establish- ment about the non-emergent nature and implications of such procedures. These procedures include infant vaginoplasties, clitoral reductions and recessions, procedures to relocate a functioning urethra, and removal of gonadal tissues, which continue to this day in New York State, even though such procedures may result in lasting harm and have been deemed human rights violations by multiple international agencies. These procedures are most often performed before a child reaches the age of two, despite no urgent medical considerations that would require immediacy in the majority of cases, meaning the individual is needlessly subjected to irreversible procedures they have not requested and that cause harm in many cases. There is evidence these procedures can cause severe physiological and psychological harm, especially when performed without the express and informed request of the individual. These harms, which often last a lifetime, may include scarring, chronic pain, urinary incontinence, sterilization, loss of future sexual sensation and function, recurring complications requiring repeated follow-up proce- dures, depression, post-traumatic stress disorder, suicidality, and incorrect gender assignment. These amendments ensure that the public information and outreach campaign on medically unnecessary treatments on intersex individuals is inclusive of both emergent and nonemergent treatments and reflects prop- er terminology, suggested by intersex individuals. The changes also ensure that meaningful stakeholder engagement occurs while the Depart- ment of Health creates the information and outreach campaign, requiring DOH to consult with appropriate stakeholders such as intersex individ- uals, intersex-led organizations, and chosen advocates such as health care providers. Through these amendments, we ensure that intersex indi- viduals are heard from and are properly addressed when creating this critical education program to ensure that we avoid preventable harms suffered by New Yorkers.   LEGISLATIVE HISTORY: This is a new bill.   BUDGET IMPLICATIONS: None noted.   EFFECTIVE DATE: This act shall take effect on the same date and in the same manner as a chapter of the laws of 2023 amending the public health law relating to requiring the department of health to conduct a public information and outreach campaign on medically unnecessary treatments on persons born with intersex traits or variations in sex characteristics, as proposed in legislative bills numbers S. 5399 and A. 5627, takes effect.
Go to top

A08482 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          8482
 
                   IN ASSEMBLY
 
                                     January 3, 2024
                                       ___________
 
        Introduced  by  M.  of  A.  SEAWRIGHT  --  read once and referred to the
          Committee on Health
 
        AN ACT to amend the public health law,  in  relation  to  treatments  on
          persons born with intersex traits
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Paragraph (r) of subdivision 1 of section 207 of the public
     2  health law, as added by a chapter of  the  laws  of  2023  amending  the
     3  public  health  law  relating  to  requiring the department of health to
     4  conduct a public information and outreach campaign on medically unneces-
     5  sary treatments on persons born with intersex traits  or  variations  in
     6  sex  characteristics,  as  proposed in legislative bills numbers S. 5399
     7  and A.  5627, is amended to read as follows:
     8    (r) The physical, sexual, and psychological  impact  of  [nonemergent]
     9  medical procedures performed on intersex individuals [with variations in
    10  sex  characteristics], including those who have not themselves consented
    11  to the procedure; provided that [such a program shall include  an  advi-
    12  sory council under this section that shall include] the department shall
    13  consult  with  appropriate  stakeholders,  including, but not limited to
    14  intersex persons [themselves], intersex-led organizations,  and  [health
    15  care  providers  with  demonstrated  medical expertise treating intersex
    16  individuals in a manner that respects their bodily integrity  and  self-
    17  determination,  among  others]  their chosen advocates, while developing
    18  this outreach program.
    19    § 2. This act shall take effect on the  same  date  and  in  the  same
    20  manner  as  a chapter of the laws of 2023 amending the public health law
    21  relating to requiring the department  of  health  to  conduct  a  public
    22  information and outreach campaign on medically unnecessary treatments on
    23  persons  born with intersex traits or variations in sex characteristics,
    24  as proposed in legislative bills numbers S.  5399  and  A.  5627,  takes
    25  effect.
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00423-02-4
Go to top